Hepatitis B Vaccine (Recombinant) Recruiting Phase 2 Trials for Hepatitis / Safety and Tolerability Prevention

IndicationsStatusPurposePhase
RecruitingPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT03685708HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I)